-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On Nuo Therapeutics with Buy Rating, Announces Price Target of $3

Benzinga·12/16/2025 15:20:55
Listen to the news
Roth Capital analyst Kyle Bauser initiates coverage on Nuo Therapeutics (OTC:AURX) with a Buy rating and announces Price Target of $3.